Trials
Search / Trial NCT05642533

Obesity and Cardiovascular Diseases, Cross-sectional Study in Saudi Arabia

Launched by NOVO NORDISK A/S · Nov 30, 2022

Apply for Trial

Trial Information

Current as of February 05, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • 1. Signed consent obtained before any study related activities (study related activities are any procedure-related to recording of data according to the protocol).
  • • 2. Diagnosed with obesity (BMI higher than or equal to 30 for all ethnic groups except Asian; BMI higher than or equal to 27.5 for patients of Asian ethnicity).
  • • 3. Diagnosed with T2D for patients in Cohort 2.
  • • 4. Male or female, aged between 18 and 75 years at the time of signing informed consent
  • Exclusion Criteria:
  • • 1. Participation in an interventional clinical trial during the study period.
  • • 2. Diagnosed with T2D for patients in Cohort 1.
  • • 3. Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation.

Trial Officials

Clinical Transparency (dept. 2834)

Study Director

Novo Nordisk A/S

About Novo Nordisk A/S

Novo Nordisk A/S is a global healthcare company headquartered in Denmark, specializing in the research, development, manufacturing, and marketing of innovative pharmaceuticals, particularly in the fields of diabetes care, obesity treatment, and hormone replacement therapies. With a strong commitment to improving patient outcomes, Novo Nordisk invests significantly in clinical trials to advance scientific knowledge and develop effective therapies. The company is dedicated to sustainability and ethical practices, striving to deliver high-quality healthcare solutions while addressing the evolving needs of patients worldwide. Through collaboration and innovation, Novo Nordisk aims to lead the way in transforming diabetes and other chronic diseases into manageable conditions.

Locations

Riyadh, , Saudi Arabia

Al Ahsa, , Saudi Arabia

Dammam, , Saudi Arabia

Ihsaa, , Saudi Arabia

Jeddah, , Saudi Arabia

Jeddah, , Saudi Arabia

Riyadh, , Saudi Arabia

Al Ahsa, , Saudi Arabia

Riyadh, , Saudi Arabia

Jeddah, , Saudi Arabia

Dammam, , Saudi Arabia

Jeddah, , Saudi Arabia

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials